InsiderClue
Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

CollPlant Biotechnologies Ltd

CLGN Clue Score46
Israel Fiscal year ends December CIK 0001631487
$3.51 -11.59% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.51 −78.91% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 30 Jan 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Fiscal year 2017Revenue0.5Operating income−6.0Net income−6.1Fiscal year 2018Revenue5.0 +982.9%Operating income−4.2Net income−6.2Fiscal year 2019Revenue2.3 −53.8%Operating income−7.6Net income−11.2EPS, diluted−2.23Fiscal year 2020Revenue6.1 +164.8%Operating income−5.6Net income−5.8EPS, diluted−0.84Fiscal year 2021Revenue15.6 +154.9%Operating income0.1Net income0.2EPS, diluted0.02Fiscal year 2022Revenue0.3 −98.1%Operating income−17.1Net income−16.9 −7,241.4%EPS, diluted−1.53Fiscal year 2023Revenue11.0 +3,565.2%Operating income−7.5Net income−7.0EPS, diluted−0.62Fiscal year 2024Revenue0.5 −95.3%Operating income−17.3Net income−16.6EPS, diluted−1.45Fiscal year 2025Revenue2.4 +360.4%Operating income−11.5Net income−11.5EPS, diluted−0.94
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.5 5.0 2.3 6.1 15.6 0.3 11.0 0.5 2.4
Growth +982.9% −53.8% +164.8% +154.9% −98.1% +3,565.2% −95.3% +360.4%
Operating income n/a −6.0 −4.2 −7.6 −5.6 0.1 −17.1 −7.5 −17.3 −11.5
Net income n/a −6.1 −6.2 −11.2 −5.8 0.2 −16.9 −7.0 −16.6 −11.5
Growth −7,241.4%
EPS, diluted n/a n/a n/a −2.23 −0.84 0.02 −1.53 −0.62 −1.45 −0.94

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Gross margin89.6%Operating margin−1,286.6%Net margin−1,306.9%Free cash flow margin−3,959.2%Fiscal year 2018Gross margin66.9%Operating margin−84.7%Net margin−124.6%Free cash flow margin−40.9%Fiscal year 2019Gross margin18.9%Operating margin−329.2%Net margin−481.6%Free cash flow margin−310.4%Fiscal year 2020Operating margin−91.2%Net margin−94.1%Free cash flow margin−79.6%Fiscal year 2021Operating margin0.4%Net margin1.5%Free cash flow margin6.9%Fiscal year 2022Operating margin−5,718.1%Net margin−5,660.5%Free cash flow margin−5,007.4%Fiscal year 2023Operating margin−68.5%Net margin−64.0%Free cash flow margin−33.9%Fiscal year 2024Operating margin−3,349.7%Net margin−3,225.0%Free cash flow margin−2,830.3%Fiscal year 2025Operating margin−484.3%Net margin−484.6%Free cash flow margin−398.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 89.6% 66.9% 18.9% n/a n/a n/a n/a n/a n/a
Operating margin n/a −1,286.6% −84.7% −329.2% −91.2% 0.4% −5,718.1% −68.5% −3,349.7% −484.3%
Net margin n/a −1,306.9% −124.6% −481.6% −94.1% 1.5% −5,660.5% −64.0% −3,225.0% −484.6%
Free cash flow margin n/a −3,959.2% −40.9% −310.4% −79.6% 6.9% −5,007.4% −33.9% −2,830.3% −398.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−19.4Capital expenditure−0.5Free cash flow−19.8Fiscal year 2017Operating cash flow−17.9Capital expenditure−0.4Free cash flow−18.3Fiscal year 2018Operating cash flow−1.2Capital expenditure−0.8Free cash flow−2.0Fiscal year 2019Operating cash flow−5.7Capital expenditure−1.5Free cash flow−7.2Fiscal year 2020Operating cash flow−4.5Capital expenditure−0.4Free cash flow−4.9Fiscal year 2021Operating cash flow2.5Capital expenditure−1.4Free cash flow1.1Fiscal year 2022Operating cash flow−13.7Capital expenditure−1.3Free cash flow−15.0 −1,495.3%Fiscal year 2023Operating cash flow−2.8Capital expenditure−1.0Free cash flow−3.7Fiscal year 2024Operating cash flow−14.1Capital expenditure−0.5Free cash flow−14.6Fiscal year 2025Operating cash flow−9.4Capital expenditure−0.0Free cash flow−9.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −19.4 −17.9 −1.2 −5.7 −4.5 2.5 −13.7 −2.8 −14.1 −9.4
Capital expenditure −0.5 −0.4 −0.8 −1.5 −0.4 −1.4 −1.3 −1.0 −0.5 −0.0
Free cash flow −19.8 −18.3 −2.0 −7.2 −4.9 1.1 −15.0 −3.7 −14.6 −9.4
Growth −1,495.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash1.1Shareholders’ equity1.5Fiscal year 2017Cash5.3Total debt2.0Net cash (debt)3.3Shareholders’ equity5.2Debt to equity0.39Fiscal year 2018Cash5.4Shareholders’ equity5.4Fiscal year 2019Cash3.8Total debt0.1Net cash (debt)3.7Shareholders’ equity4.1Debt to equity0.02Fiscal year 2020Cash3.3Total debt0.0Net cash (debt)3.3Shareholders’ equity4.5Debt to equity0.00Fiscal year 2021Cash13.1Total debt0.0Net cash (debt)13.1Shareholders’ equity45.1Debt to equity0.00Fiscal year 2022Cash29.7Shareholders’ equity32.3Fiscal year 2023Cash26.7Shareholders’ equity28.3Fiscal year 2024Cash11.9Shareholders’ equity13.5Fiscal year 2025Cash5.6Shareholders’ equity6.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 1.1 5.3 5.4 3.8 3.3 13.1 29.7 26.7 11.9 5.6
Total debt n/a 2.0 n/a 0.1 0.0 0.0 n/a n/a n/a n/a
Net cash (debt) n/a 3.3 n/a 3.7 3.3 13.1 n/a n/a n/a n/a
Shareholders’ equity 1.5 5.2 5.4 4.1 4.5 45.1 32.3 28.3 13.5 6.1
Debt to equity n/a 0.39 n/a 0.02 0.00 0.00 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−19.4 −17.9 −1.2 −5.7 −4.5 2.5 −13.7 −2.8 −14.1 −9.4
Growth −647.7%
n/a n/a n/a n/a n/a 0.8 1.1 1.1 1.0 0.9
Investment
−0.5 −0.4 −0.8 −1.5 −0.4 −1.4 −1.3 −1.0 −0.5 −0.0
calc −19.8 −18.3 −2.0 −7.2 −4.9 1.1 −15.0 −3.7 −14.6 −9.4
Growth −1,495.3%
calc n/a n/a n/a −1.44 −0.71 0.09 −1.36 −0.33 −1.27 −0.77
−0.5 −0.4 −0.8 −1.5 −0.5 −31.6 28.9 −1.2 −0.5 −0.0
Financing
18.5 32.4 2.8 5.4 4.5 38.8 1.9 1.1 0.0 3.1

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.